Metraipolis › archive › dc_5cfbb8a84c6e
Advice to the FDA to Improve Its Proposed Guidelines to Rationalize Clinical Trials by Restricting Placebo Control, Preventing Low-Powered Studies, and… — Europe PMC PMID:39598336
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/39598336
- DOI
- 10.3390/ph17111424
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T04:30:05.640Z
- SHA-256 of the archived text
f9030eebd5200054c9be9b0c47ef635a2e2729938b7ef73f7baf778c91031411- Stable URL of this page
https://metraipolis.com/documento/dc_5cfbb8a84c6e
How to cite
Advice to the FDA to Improve Its Proposed Guidelines to Rationalize Clinical Trials by Restricting Placebo Control, Preventing Low-Powered Studies, and… — Europe PMC PMID:39598336 — Europe PMC (en), https://europepmc.org/article/MED/39598336 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5cfbb8a84c6e (Metraipolis archive dc_5cfbb8a84c6e, sha256 f9030eebd5200054c9be9b0c47ef635a2e2729938b7ef73f7baf778c91031411)
BibTeX
@misc{dc5cfbb8a84c6e,
title = {Advice to the FDA to Improve Its Proposed Guidelines to Rationalize Clinical Trials by Restricting Placebo Control, Preventing Low-Powered Studies, and… — Europe PMC PMID:39598336},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/39598336},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5cfbb8a84c6e; sha256 f9030eebd5200054c9be9b0c47ef635a2e2729938b7ef73f7baf778c91031411},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39598336. Agents can read the archived copy with the MCP tool read_document.